UniProtKB/Swiss-Prot P12259: Variant p.Leu1285Ile

Coagulation factor V
Gene: F5
Feedback?

Variant information Variant position:

1285 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Leucine (L) to Isoleucine (I) at position 1285 (L1285I, p.Leu1285Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1046712 [ dbSNP | Ensembl ]

Sequence information Variant position:

1285 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

2224 The length of the canonical sequence.
Location on the sequence:

TNLSPALGQMPLSPDLSHTT L SLDFSQTNLSPELSHMTLSP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TNLSPALGQMPLSPDLSHTTLSLDFSQTNLSPELSHMTLSP

Mouse                         KTSSPDLGQVPLSLDDNQKTTSPDLGQVPLSPDDNQMITSP

Pig                           TTLSPDLGHTTLSPDLSHTTLSPDLGHATLSPDLSHTTLSP

Bovine                        ESLSPDLGQTALSPDPGQESLSPDLGQTSLSPDLSQESLSP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	29 – 2224	Coagulation factor V
Propeptide	738 – 1573	Activation peptide (connecting region)
Repeat	1284 – 1292	2-12
Region	692 – 1573	B
Region	1185 – 1501	35 X 9 AA approximate tandem repeats of [TNP]-L-S-P-D-L-S-Q-T

Literature citations
Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT THPH2 GLN-534; VARIANTS SER-15; HIS-107; THR-413; LYS-513; SER-809; THR-817; ARG-858; ARG-865; SER-915; GLU-925; SER-969; LEU-980; GLN-1146; ILE-1285; SER-1404; ALA-1530 AND THR-2148; Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats.
Kane W.H.; Ichinose A.; Hagen F.S.; Davie E.W.;
Biochemistry 26:6508-6514(1987)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-1600; VARIANTS ARG-858; ARG-865; GLU-925 AND ILE-1285; Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma.
Lunghi B.; Iacoviello L.; Gemmati D.; Dilasio M.G.; Castoldi E.; Pinotti M.; Castaman G.; Redaelli R.; Mariani G.; Marchetti G.; Bernardi F.;
Thromb. Haemost. 75:45-48(1996)
Cited for: VARIANTS ILE-1285 AND ARG-1327;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.